Tectonic Therapeutic | AVRO - Sales Revenues

Stock Price
21.37
Daily Change
0.37 1.76%
Monthly
13.43%
Yearly
-27.66%
Q1 Forecast
20.71

Tectonic Therapeutic reported $0 in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Akebia Therapeutics USD 57.34M 10.84M Mar/2025
Alnylam Pharmaceuticals USD 1.1B 150M Dec/2025
Celltrion KRW 1.33T 300B Mar/2026
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Karyopharm Therapeutics USD 30.54M 8.24M Dec/2024
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
MacroGenics USD 72.84M 50.6M Sep/2025
Medical Developments International AUD 9.53M 1.99M Jun/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Organigram Holdings CAD 80.06M 9.27M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Pharma Mar EUR 35.7M 20.69M Sep/2025
Qiagen NV USD 457.38M 6.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sangamo BioSciences USD 356K 125K Jun/2024
Sanofi EUR 11.3B 1.13B Dec/2025
Sarepta Therapeutics USD 399.4M 211.69M Sep/2025
Sartorius EUR 927.6M 84.4M Dec/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Takeda JPY 1.19T 80B Dec/2025
Tilray USD 217.51M 74.75M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025